A panel of three proteins consisting of 14-3-3 theta, annexin I and PGP 9.5 proteins, gave a sensitivity of 55% at 95% specificity in discriminating lung cancer at the preclinical stage from controls [47]. The gene discussed is ANXA1; the disease is lung carcinoma.